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In the field of quality of health care measurement, one approach
to assessing patient sickness at admission involves a logistic regression
of mortality within 30 days of admission on a fairly large number of
sickness indicators (on the order of 100) to construct a sickness scale,
employing classical variable selection methods to find an “optimal”
subset of 10–20 indicators. Such “benefit-only” methods ignore the
considerable differences among the sickness indicators in cost of data
collection, an issue that is crucial when admission sickness is used
to drive programs (now implemented or under consideration in sev-
eral countries, including the U.S. and U.K.) that attempt to identify
substandard hospitals by comparing observed and expected mortal-
ity rates (given admission sickness). When both data-collection cost
and accuracy of prediction of 30-day mortality are considered, a large
variable-selection problem arises in which costly variables that do not
predict well enough should be omitted from the final scale.
In this paper (a) we develop a method for solving this problem
based on posterior model odds, arising from a prior distribution that
(1) accounts for the cost of each variable and (2) results in a set of
posterior model probabilities that corresponds to a generalized cost-
adjusted version of the Bayesian information criterion (BIC), and
(b) we compare this method with a decision-theoretic cost-benefit ap-
proach based on maximizing expected utility. We use reversible-jump
Markov chain Monte Carlo (RJMCMC) methods to search the model
space, and we check the stability of our findings with two variants of
the MCMC model composition (MC 3) algorithm. We find substan-
tial agreement between the decision-theoretic and cost-adjusted-BIC
methods; the latter provides a principled approach to performing a
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cost-benefit trade-off that avoids ambiguities in identification of an
appropriate utility structure. Our cost-benefit approach results in a
set of models with a noticeable reduction in cost and dimensionality,
and only a minor decrease in predictive performance, when compared
with models arising from benefit-only analyses.
1. Introduction. An important topic in health policy is the assessment
of the quality of health care offered to hospitalized patients. Quality of care
is usually thought to depend mainly on three ingredients [e.g., Donabedian
and Bashshur, (2002)]: (i) process, which is what health care providers do
on behalf of patients, (ii) outcomes, which are what happens to patients
as a result of the care they receive, and (iii) patient sickness at admission,
because the appropriateness of outcomes cannot be judged without taking
account of the burden of illness brought to the hospital by its patients.
A direct audit of the processes of care is usually regarded as the single
most informative component in an evaluation of quality, but process is much
more expensive to measure than outcomes or admission sickness [e.g., Kahn
et al. (1990a); Schuster et al. (2005)]. Interest has therefore focused in recent
years, in countries such as the United States and the United Kingdom, on
an indirect method of assessment—which might be termed the input-output
approach1 [e.g., Draper (1995); Olhssen et al. (2007)]—in which hospital
outcomes (for instance, death within 30 days of admission) are compared
after adjusting for differences in inputs (sickness at admission). The idea is
to treat what goes on inside the hospital—process—as a black box, with the
contents of the box inferred by examining its outputs after taking account
of its inputs.
1.1. Indirect measurement of quality of health care. In practice, to indi-
rectly measure quality of care at any given moment in time, this strategy
proceeds by (a) taking a sample of hospitals and a sample of patients in the
chosen hospitals, (b) obtaining mortality outcomes for the sampled patients
(e.g., from central government data bases), (c) extracting information on
admission sickness from the medical records of these patients, (d) forming
an expected mortality rate for each hospital based on (c), and (e) compar-
ing observed and expected mortality rates to identify unusual hospitals (on
both the “good” and “bad” ends of the spectrum). Since this would involve
abstracting data from the charts of many thousands of patients if it were
attempted on a large scale, the cost-effective measurement of admission sick-
ness is crucial to this approach. Progress is being made in the U.S. [see, e.g.,
1In the U.K. this approach is also referred to as league-table quality assessment [e.g.,
Goldstein and Spiegelhalter (1996)], by analogy with the process of ranking football (soc-
cer) teams; in the U.S. and elsewhere it is also called provider profiling [e.g., Zhang et al.
(2006)].
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CMS (2008), for details on Medicare’s plans to compile a Uniform Clinical
Data Set] and elsewhere on real-time electronic data collection of clinically
richer sets of process and sickness variables for hospital patients than those
previously available from administrative data bases, but it is likely to remain
true for at least the next decade that cost-effective collection of data from
nonelectronic medical records will be relevant to the design of quality of care
studies in health policy [see, e.g., NDNQI (2008), and CalNOC (2008), for
current examples, in the field of nursing quality assessment, where extensive
nonautomated primary data collection is both ongoing and planned]. This is
particularly true in countries with an interest in quality of care measurement
but insufficient resources to be at the cutting edge in medical informatics.
Quality of care assessment is a highly disease-specific activity: for instance,
the best admission sickness variables to examine for pneumonia would be
quite different from those for heart attack.2 With any given disease there
will be on the order of 100 separate variables potentially available in the
medical record that are directly or indirectly related to admission sickness.
In the case of pneumonia, for example, on which we focus in this paper,
a list of the important variables from a clinical perspective would include
such things as systolic blood pressure on day 1 of admission, the presence or
absence of shortness of breath, and the blood urea nitrogen level (a measure
of kidney functioning).
1.2. Standard benefit-only variable-selection approach. One standard
method for creating an expected mortality rate from these admission sickness
inputs is logistic regression, with 30-day death as the outcome, and using
a nationally-representative sample of patients to normalize the expectation
to average care across the nation. Typically a frequentist variable-selection
method—such as backward selection from the model with all predictors—
is employed to find a parsimonious and clinically reasonable subset of the
available sickness variables. In a major U.S. study conducted by the RAND
Corporation, of quality of hospital care for 16,758 elderly patients in the late
1980s [Kahn et al. (1990b)], this approach was used to reduce the initial list
of p= 83 available sickness indicators gathered on the n= 2,532 pneumonia
patients in the study down to a core of 14 predictors [Keeler et al. (1990)].
As good as the resulting scale may be on grounds of simplicity and ease of
clinical communication, we take the view in this paper that—when the goal
2Note that this approach to quality assessment is effective only with diseases, such as
pneumonia and heart attack, for which there is a strong process-outcome link (i.e., such
that good care leads to good outcomes and bad care to bad outcomes); with an incurable
illness given present medical understanding (such as end-stage renal disease), mortality is
irrelevant, since all patients die relatively quickly no matter what processes of care they
receive.
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is the creation of a sickness scale that may be used prospectively to mea-
sure quality of care on a new set of patients not yet examined—the original
RAND approach is sub-optimal, because it takes no account of differences in
the cost of data collection among the available predictors (which varied for
pneumonia from 30 seconds to 10 minutes of abstraction time per variable).
The RAND approach represents a kind of benefit-only analysis; we propose
a cost-benefit analysis, in which variables are chosen for the final scale only
when they predict mortality well enough given how much they cost to col-
lect. The relevance of this cost-benefit perspective is seen by noting that,
in practice, the amount of money devoted to quality assessment will almost
invariably be constrained, so that money wasted on excess data collection
costs could be better spent on obtaining (e.g.) a larger sample size at the
patient and/or hospital levels.
Table 1 lists the 14 variables chosen by the benefit-only RAND approach,
together with their marginal data collection costs per patient (expressed in
minutes of data abstraction time; this could be transformed to a monetary
scale with a map of the form c 7→ αc with α > 0, using the prevailing wage
rate for qualified data abstraction personnel, but there is nothing to be
gained from such a transformation). The full list of all 83 sickness indicators
for pneumonia is examined in Section 4.2, where columns 4–6 of Table 1 are
explained.
1.3. Cost-benefit and cost-restriction-benefit analyses. Weighing data-collec-
tion costs against the accuracy of prediction creates a large variable-selection
problem; for example, with p= 83 it is necessary to compare 283
.
= 9.7 · 1024
subsets of sickness variables in order to find the optimal subset. Solving this
problem by brute-force examination of all 1025 models is sharply infeasible
given contemporary computing resources.
Following Fouskakis (2001), suppose (a) the 30-day mortality outcome
Yi and data on p sickness indicators (Xi1, . . . ,Xip) have been collected on
n individuals chosen exchangeably from a population P of patients with a
given disease, and (b) the goal is to predict the death outcome for n∗ new
patients who will in the future be sampled randomly from P , (c) on the
basis of some or all of the predictors Xj , when (d) the marginal costs of
data collection per patient c1, . . . , cp for the Xj vary considerably. What is
the best subset of the Xj to choose based on both the quality and the cost
of obtaining the predictions?
In problems such as this, in which there are two desirable criteria—in this
case, low cost and high predictive accuracy—that compete, and over which
a joint optimization must be achieved, there are two main ways to proceed:
(a) (cost-benefit) both criteria can be placed on a common scale, trading
one off against the other, and optimization can occur on that scale, or
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Table 1
The RAND admission sickness scale for pneumonia (p= 14 variables), with the marginal
data collection costs per patient for each variable (in minutes of abstraction time);
columns 4–6 are explained in Section 4.2
Method
Variable Utility RJMCMC
Cost Posterior
Index Name (minutes) Good? Good? probability
1 Systolic blood pressure 0.5 ∗∗ ∗∗ 0.99
score (2-point scale)
2 Age 0.5 ∗ ∗∗ 0.99
3 Blood urea nitrogen 1.5 ∗∗ ∗∗ 1.00
4 APACHE II coma 2.5 ∗∗ ∗∗ 1.00
score (3-point scale)
5 Shortness of breath day 1 (yes, no) 1.0 ∗∗ ∗∗ 0.99
6 Serum albumin score (3-point scale) 1.5 ∗ ∗∗ 0.55
7 Respiratory distress (yes, no) 1.0 ∗ ∗∗ 0.92
8 Septic complications (yes, no) 3.0 0.00
9 Prior respiratory failure (yes, no) 2.0 0.00
10 Recently hospitalized (yes, no) 2.0 0.00
12 Initial temperature 0.5 ∗ ∗∗ 0.95
17 Chest X-ray congestive 2.5 0.00
heart failure score (3-point scale)
18 Ambulatory score (3-point scale) 2.5 0.00
48 Total APACHE II 10.0 0.00
score (36-point scale)
(b) (cost-restriction-benefit) one criterion can be optimized, subject to a
bound on the other.
Here we present results from one possible implementation of approach
(a), in which we identify a prior distribution that (1) accounts for the cost
of each variable in a natural way and (2) results in a set of posterior model
probabilities that correspond to a generalized cost-adjusted version of the
Bayesian information criterion (BIC). To incorporate preferences based on
costs of the variables, we use a Laplace approximation to obtain a cost-based
penalty for each variable. After setting up the prior model and variable
probabilities, we use reversible-jump Markov chain Monte Carlo to search
the model space. The data on which we demonstrate our method in this
paper consist of the representative sample of n = 2,532 elderly American
patients hospitalized in the period 1980–86 with pneumonia taken from the
RAND study described above.
The plan of the paper is as follows. In Section 2 we describe the approach
we investigated in this study, and Section 3 provides details concerning the
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computation. Section 4 illustrates the experimental results on the pneumo-
nia data set using the method described in Sections 2 and 3, and includes
a comparison of the results from our method and those from another pos-
sible implementation [Fouskakis and Draper (2008)] of approach (a) based
on maximizing expected utility. [Brown et al. (1998) presented an applica-
tion of decision theory to variable selection in multivariate regression that
is motivated by somewhat similar cost-benefit considerations in a quite dif-
ferent setting; Lindley (1968) used squared-error loss to measure predictive
accuracy while recommending a cost-benefit tradeoff in variable selection in
a less problem-specific framework than the one presented here.] In Section 5
we conclude the paper with a brief discussion of some statistical and quality
assessment implications of our work.
2. A Bayesian approach to cost-effective variable selection. Bayesian
parametric model comparison and variable selection are based on specify-
ing a model m, its likelihood f(y|θm,m), the prior distribution of model
parameters f(θm|m) and the corresponding prior model weight (or prob-
ability) f(m), where θm is a parameter vector under model m and y is
the data vector. Parametric inference is based on the posterior distribution
f(θm|y,m), and quantifying model uncertainty by estimating the posterior
model probabilities f(m|y) is also an important issue. Hence, when we con-
sider a set of competing models M= {m1,m2, . . . ,m|M|}, we focus on the
posterior probability of model m ∈M, defined as
f(m|y) =
f(y|m)f(m)∑
mℓ∈M
f(y|mℓ)f(mℓ)
=
( ∑
mℓ∈M
POmℓ,m
)−1
(1)
=
[ ∑
mℓ∈M
Bmℓ,m
f(mℓ)
f(m)
]−1
,
where POmk,mℓ =
f(mk |y)
f(mℓ|y)
is the posterior model odds, and Bmk ,mℓ is the
Bayes factor, for comparing models mk and mℓ. When we limit ourselves
in the comparison of only two models we typically focus on POmk ,mℓ and
Bmk ,mℓ , which have the desirable property of insensitivity to the selection
of the model space M. By definition, the Bayes factor is the ratio of the
posterior model odds over the prior model odds; thus, large values of Bmk ,mℓ
(usually greater than 12, say) indicate strong posterior support of model mk
against model mℓ [for details see, e.g., Raftery (1996)]. The posterior model
probabilities and integrated likelihoods f(y|mℓ) in (1) are rarely analytically
tractable; we use a combination of Laplace approximations [e.g., Bernardo
and Smith (1994)] and Markov Chain Monte Carlo (MCMC) methodology
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[e.g., Green (1995); Han and Carlin (2001); Chipman et al. (2001); Della-
portas et al. (2002); Lopes (2002)] to approximate posterior odds and Bayes
factors.
In the problem described in Section 1, we use a simple logistic regression
model with response Yi = 1 if patient i dies within 30 days of admission
and 0 otherwise. We further denote by Xij the sickness predictor variable j
for patient i and by γj an indicator, often used in Bayesian variable selec-
tion problems [e.g., George and McCulloch (1993); Kuo and Mallick (1998);
Brown et al. (1998); Dellaportas et al. (2002)], taking the value 1 if variable
j is included in the model and 0 otherwise. Thus, in this case M= {0,1}p,
where p is the total number of variables. In order to map the set of binary
model indicators γ onto a model m, we can use a representation of the form
m(γ) =
∑p
j=1 2
j−1γj . Hence, the model formulation can be summarized as
(Yi|γ)
indep
∼ Bernoulli[pi(γ)],
ηi(γ) = log
[
pi(γ)
1− pi(γ)
]
=
p∑
j=0
βjγjXij ,(2)
η(γ) = Xdiag(γ)β =Xγβγ,
defining Xi0 = 1 for all i = 1, . . . , n and γ0 = 1 with prior probability one
since here the intercept is always included in all models. Here pi(γ) is
the death probability (which may be thought of as the sickness score) for
patient i under model γ, η(γ) = [η1(γ), . . . , ηn(γ)]
T , γ = (γ0, γ1, . . . , γp)
T ,
β = (β0, β1, . . . , βp)
T , and X = (Xij , i = 1, . . . , n; j = 0,1, . . . , p). The vector
βγ stands for the subvector of β included in the model specified by γ, that
is, βγ = (βj :γj = 1, j = 0,1, . . . , p), and is equivalent to the θm vector de-
fined at the beginning of this section; similarly, Xγ is the submatrix of X
with columns corresponding to variables included in the model specified by
γ.
In the remainder of this section we illustrate how to build a prior dis-
tribution to accommodate in the posterior distribution a penalty function
for the increased cost of expensive predictor variables. To this end, we first
build a minimally informative prior for the model parameters based on the
ideas of Ntzoufras et al. (2003). Then we employ a Laplace approximation
[e.g., Tierney and Kadane (1986)] to examine the penalty (indirectly) im-
posed upon the model likelihood using the Bayesian approach. Finally, we
specify prior model weights (probabilities) in such a way that the posterior
model probabilities in effect result from a likelihood penalized according to
the cost of each variable in the model.
2.1. Prior on model parameters. One important problem in Bayesian
model evaluation using posterior model probabilities is their sensitivity to
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the prior variance of the model parameters: large variance of the βγ (used
to represent prior ignorance) will increase the posterior probabilities of the
simpler models considered in the model space M [Bartlett (1957); Lindley
(1957); Shafer (1982); Robert (1993); Kass and Raftery (1995); Sinharay
and Stern (2002)]. Therefore, specifying the prior distribution is pivotal for
the a posteriori support of the models examined. We address this issue with
ideas proposed by Ntzoufras et al. (2003): we use a prior distribution of the
form
f(βγ|γ) =N(µγ,Σγ),(3)
with prior covariance matrix given by Σγ = n[I(βγ)]
−1, where n is the total
sample size and I(βγ) is the information matrix
I(βγ) =X
T
γWγXγ;(4)
here Wγ is a diagonal matrix, which in the Bernoulli case [e.g., McCullagh
and Nelder (1983)] takes the form
Wγ = diag{pi(γ)[1− pi(γ)]}.(5)
This is the unit information prior introduced by Kass and Wasserman
(1996), which corresponds to adding one data point to the data. Here we use
this prior as a base, but we specify pi(γ) in the information matrix according
to our prior information. In this manner we avoid (even minimal) reuse of
the data in the prior.
When little prior information is available, a reasonable prior mean for βγ
is µγ = 0. This corresponds to a prior mean on the log-odds scale of zero,
from which a sensible prior estimate for all model probabilities is pi(γ) = 1/2;
with this choice (3) becomes
f(βγ|γ) =N [0,4n(X
T
γXγ)
−1].(6)
This prior distribution can also be motivated by combining the idea of imag-
inary data with the power-prior approach of Chen et al. (2000); for details,
see Fouskakis, Ntzoufras and Draper (2009a).
2.2. A cost-penalized prior on model space. The aim of this subsection is
to specify a set of prior model probabilities (or odds) that accounts for prior
preferences based on the variable costs. To make this more explicit, we first
describe preliminary results concerning the posterior model probabilities
f(γ|y) and the corresponding model odds using the prior distribution (6),
when no assumption is made for the prior model probability f(γ). We then
specify a prior on the model space that takes into account prior preferences
based on the cost of the variables. In order to achieve this, we use a penalty-
based interpretation of the prior f(γ) imposed on the log-likelihood that
directly results from the first subsection. Finally, we use this cost-penalized
model prior to calculate the posterior model probabilities and odds.
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2.2.1. Preliminary results: posterior probabilities and model odds in the
general setup. Let us denote by POkℓ and Bkℓ the posterior odds and Bayes
factor respectively of model γ(k) versus model γ(ℓ). Then we have
− 2 logPOkℓ =−2[log f(γ
(k)|y)− log f(γ(ℓ)|y)]
=−2 log
(
f(y|γ(k))
f(y|γ(ℓ))
)
− 2 log
f(γ(k))
f(γ(ℓ))
(7)
=−2 logBkℓ + ξ(γ
(k),γ(ℓ)),
where ξ(γ(k),γ(ℓ)) is the extra penalty imposed on minus twice the logarithm
of the Bayes factor through the prior model probabilities.
Following the approach of Raftery (1996), we can approximate the poste-
rior distribution of a model γ using the following Laplace approximation:
− 2 log f(γ|y) =−2 log f(y|β˜γ,γ)− 2 log f(β˜γ|γ)− dγ log(2pi)
(8)
− log |Ψγ| − 2 log f(γ) +O(n
−1),
where β˜γ is the posterior mode of f(βγ|y,γ), dγ =
∑p
j=0 γj is the dimension
of the model γ, andΨγ is minus the inverse of the Hessian matrix of h(βγ) =
log f(y|βγ,γ)+ log f(βγ|γ) evaluated at the posterior mode β˜γ. Under the
model formulation given by equation (2) and the prior distribution (6), we
have that
Ψγ =
[
−
∂2 log f(y|βγ,γ)
∂β2γ
∣∣∣∣
βγ=β˜γ
−
∂2 log f(βγ|γ)
∂β2γ
∣∣∣∣
βγ=β˜γ
]−1
(9)
=
(
XTγ diag
{
exp(Xγ,iβ˜γ)
[1 + exp(Xγ,iβ˜γ)]
2
+
1
4n
}
Xγ
)−1
,
where Xγ,i is row i of the matrix Xγ for i= 1, . . . , n.
By substituting the prior (6) in expression (8), we obtain
− 2 log f(γ|y) =−2 log f(y|β˜γ,γ) + [φ(γ)− 2 log f(γ)] +O(n
−1),(10)
where
φ(γ) =
1
4n
β˜
T
γX
T
γXγβ˜γ + dγ log(4n) + log
|Ψ−1γ |
|XTγXγ|
.(11)
From the above expression it is clear that the logarithm of a posterior model
probability can be regarded as a penalized log-likelihood evaluated at the
posterior mode of the model, in which the term [φ(γ)−2 log f(γ)] can be in-
terpreted as the penalty imposed upon the log-likelihood. In pairwise model
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comparisons, we can directly use the posterior model odds (7), which can
now be written as
− 2 logPOkℓ =−2 log
{
f(y|β˜γ(k) ,γ
(k))
f(y|β˜γ(ℓ) ,γ
(ℓ))
}
(12)
+
[
φ(γ(k))− φ(γ(ℓ))− 2 log
f(γ(k))
f(γ(ℓ))
]
+O(n−1).
Therefore, the comparison of the two models is based on a penalized log-
likelihood ratio, where the penalty is now given by
ψ(γ(k),γ(ℓ)) = φ(γ(k))− φ(γ(ℓ))− 2 log
f(γ(k))
f(γ(ℓ))
;(13)
for more details see Ntzoufras (1999), Chapter 6.
Each penalty term is divided into two parts: φ(γ) and −2 log f(γ). The
first term, φ(γ), has its source in the marginal likelihood f(y|γ) of model
γ and can be thought of as a measure of discrepancy between the data and
the prior information for the model parameters. The second part comes from
the prior model probabilities f(γ). Indifference on the space of all models,
usually expressed by the uniform distribution [i.e., f(γ)∝ 1], eliminates the
second term from the model comparison procedure, since the penalty term
in (12) will then be based only on the difference of the first penalty terms
φ(γ(k)) − φ(γ(ℓ)). For this reason the penalty term φ(γ) is the imposed
penalty that appears in the penalized log-likelihood expression of the Bayes
factor Bkℓ with a uniform prior on model space.
A simpler but less accurate approximation of logPOkℓ can be obtained
following the arguments of Schwarz (1978):
− 2 logPOkℓ =−2 log
[
f(y|βˆγ(k) ,γ
(k))
f(y|βˆγ(ℓ) ,γ
(ℓ))
]
(dγ(k) − dγ(ℓ)) logn
− 2 log
f(γ(k))
f(γ(ℓ))
+O(1)(14)
= BIC kℓ− 2 log
f(γ(k))
f(γ(ℓ))
+O(1),
where BIC kℓ is the Bayesian Information Criterion [e.g., Kass and Wasser-
man (1996); Raftery (1995, 1996); Hoeting et al. (1999)] for choosing between
models γ(k) and γ(ℓ) and βˆγ is the vector of maximum likelihood estimates
of βγ. Since BIC kℓ is an O(1) approximation, it might diverge from the ex-
act value of the logarithm of the Bayes factor even for large samples. Even
so, it has often been shown to provide a reasonable measure of evidence (for
finite n) and its straightforward calculation has encouraged its widespread
use in practice [see Kass and Raftery (1995) for details].
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2.2.2. Accounting for the cost of variables via prior model weights. Fol-
lowing the previous section and equations (7), (10) and (12), it is clear
that an additional penalty ξ can be directly imposed on terms of the form
−2 logBkl via the prior model probabilities f(γ). Here we propose to specify
our prior model probabilities via cost-dependent penalties for each variable.
We do this by identifying a baseline cost c0 and then specifying the other
costs in relation to the baseline in a way that appropriately generalizes BIC.
We specify our prior distribution on γ to satisfy the following five criteria:
(a) The marginal costs (c1, . . . , cp) should enter into the prior in a manner
that is invariant under maps of the form c 7→ αc with α > 0, so that
conversion between time and money (see Section 1.2) or between mea-
surements of money on different scales (e.g., dollars and euros) leaves
the prior unchanged;
(b) the extra penalty ξ1 for adding a variable Xj with baseline cost c0, above
and beyond that in a benefit-only analysis, is zero;
(c) the extra penalty ξ2 for adding a variable Xj with cost cj = κc0 for some
κ > 1, above and beyond that in a benefit-only analysis, equals the BIC
penalty of (κ− 1) variables with cost c0;
(d) the extra penalty ξ3 for adding any variable Xj , above and beyond that
in a benefit-only analysis, is greater or equal to zero; and
(e) if all the variables have the same cost, then the prior must reduce to the
uniform prior on γ.
The first requirement ensures that the prior is invariant with respect to
the manner in which cost is measured. The second criterion ensures that
the penalty for adding a variable Xj with baseline cost c0 is the same as
in the benefit-only analysis. Concerning the third requirement, the propor-
tionality of the extra penalty to the BIC penalty (logn) ensures that the
posterior model odds will still have a BIC-like behavior. Moreover, the ex-
tra penalty induced by this type of prior will equal the relative difference
between the cost of the variable Xj and a variable with cost equal to c0.
The fourth requirement ensures that the cost-benefit analysis will support
more parsimonious models, in terms of both dimensionality and cost, than
the corresponding models supported by the benefit-only analysis under the
uniform prior on the model space. Finally, the fifth criterion requires that
our prior should reproduce the benefit-only analysis if all costs are equal.
The following theorem, whose proof is given in Appendix A, provides the
only prior that meets the above five requirements, and defines the choice of
c0.
Theorem 1. If a prior distribution f(γ) satisfies requirements (a)–(e)
above, then it must be of the form
f(γj)∝ exp
[
−
γj
2
(
cj
c0
− 1
)
logn
]
for j = 1, . . . , p,(15)
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where cj is the marginal cost per observation for variable Xj and c0 =
min{cj , j = 1, . . . , p}.
To the above definition of our prior we add the further assumption that
the constant term is included in all models by specifying f(γ0 = 1) = 1,
resulting in
− 2 log f(γ) =
p∑
j=1
γj
cj
c0
logn− dγ logn+2
p∑
j=1
log[1 + n−(1−cj/c0)/2].(16)
When comparing two models γ(k) and γ(ℓ), the additional penalty im-
posed on the log-likelihood ratio due to the cost-adjusted prior model prob-
abilities is given by
− 2 log
[
f(γ(k))
f(γ(ℓ))
]
=
p∑
j=1
(γ
(k)
j − γ
(ℓ)
j )
cj
c0
logn− (dγ(k) − dγ(ℓ)) logn
(17)
=
[
Cγ(k) −Cγ(ℓ)
c0
− (dγ(k) − dγ(ℓ))
]
logn,
where Cγ =
∑p
j=1 γjcj is the total cost of model γ; thus, two models of the
same dimension and cost will have the same prior weight.
Using the prior model odds (17) in the approximate posterior model odds
(12), we obtain
− 2 logPOkℓ =−2 log
[
f(y|β˜γ(k) ,γ
(k))
f(y|β˜γ(ℓ) ,γ
(ℓ))
]
+ψ(γ(k),γ(ℓ)) +O(n−1),(18)
where the penalty term is given by
ψ(γ(k),γ(ℓ)) =
1
4n
(β˜T
γ(k)
XT
γ(k)
Xγ(k) β˜γ(k) − β˜
T
γ(ℓ)
XT
γ(ℓ)
Xγ(ℓ) β˜γ(ℓ))
+ (dγ(k) − dγ(ℓ)) log(4)(19)
+ log
|Ψ−1
γ(k)
|
|XT
γ(k)
Xγ(k) |
− log
|Ψ−1
γ(ℓ)
|
|XT
γ(ℓ)
Xγ(ℓ) |
+
Cγ(k) −Cγ(ℓ)
c0
logn.
Finally, we consider the BIC-based approximation (14) to the logarithm
of the posterior model odds with the prior model odds (17), yielding
− 2 logPOkℓ =−2 log
[
f(y|βˆγ(k) ,γ
(k))
f(y|βˆγ(ℓ) ,γ
(ℓ))
]
+
Cγ(k) −Cγ(ℓ)
c0
logn+O(1).(20)
The penalty term dγ logn of model γ used in (14) has been replaced in the
above expression by the cost-dependent penalty c−10 Cγ logn; ignoring costs
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is equivalent to taking cj = c0 for all j, yielding c
−1
0 Cγ = dγ, the original
BIC expression. Therefore, we may interpret the quantity logn as the im-
posed penalty for each variable included in the model γ when no costs are
considered (or when costs are equal). Moreover, this baseline penalty term is
inflated proportionally to the cost ratio
cj
c0
for each variable Xj ; for example,
if the cost of a variable Xj is twice the minimum cost (cj = 2c0), then the
imposed penalty is equivalent to adding two variables with the minimum
cost. For all these reasons, (20) can be considered as a cost-adjusted gener-
alization of BIC when prior model probabilities of type (15) are adopted.
To summarize the effect of our prior on the posterior model odds, consider
any two models γ(k) and γ(ℓ). From (14) the penalty imposed on the log-
likelihood ratio is given by
ω(γ(k),γ(ℓ)) = (dγ(k) − dγ(ℓ)) logn− 2 log
f(γ(k))
f(γ(ℓ))
(21)
= (dγ(k) − dγ(ℓ)) logn− ξ(γ
(k),γ(ℓ)).
Then (15), with c0 =min{cj , j = 1, . . . , p}, is the only form for a prior dis-
tribution that leads in a natural way to our approach being equivalent to
a cost-adjusted version of BIC with the following properties: (a) if the cost
of a variable Xj is κ times the minimum cost, then the imposed penalty
ω is equivalent to adding κ variables with the minimum cost; (b) our ap-
proach always results in models more parsimonious than BIC when costs
are unequal, and (c) our prior reduces to BIC when all costs are equal (this
result is summarized as Corollary 1 in Appendix A, where a proof is also
provided).
3. MCMC implementation. With a realistically large number of predic-
tors, the model space in our problem is too large for full-enumeration or naive
Monte Carlo strategies to estimate posterior model probabilities with high
accuracy in a reasonable amount of CPU time. For this reason, we adopted
a different approach and implemented the following two-step method:
(1) First we used a model search tool to identify variables with high marginal
posterior inclusion probabilities f(γj|y), and we created a reduced model
space consisting only of those variables whose marginal probabilities
were above a threshold value. According to Barbieri and Berger (2004),
this method of selecting variables based on their marginal probabilities
may lead to the identification of models with better predictive abili-
ties than approaches based on maximizing posterior model probabili-
ties. Although Barbieri and Berger proposed 0.5 as a threshold value
for f(γj = 1|y), we used the lower value of 0.3, since our aim was only
to identify and eliminate variables not contributing to models with high
posterior probabilities.
14 D. FOUSKAKIS, I. NTZOUFRAS AND D. DRAPER
(2) Then we used the same trans-dimensional MCMC algorithm as in step
(1) in the reduced space to estimate posterior model probabilities (and
the corresponding odds).
To ensure stability of our findings, we explored the use of two model search
tools in step (1):
• a reversible-jump MCMC algorithm [RJMCMC; Green (1995)], as imple-
mented for variable selection in generalized linear models by Dellaportas
et al. (2002) and Ntzoufras et al. (2003); and
• the MCMC model composition (MC 3) algorithm [Madigan and York
(1995)].
More specifically, we implemented reversible-jump moves within Gibbs for
the model indicators γj , by proposing the new model to differ from the
current one in each step by a single term j with probability one [Dellaportas
et al. (2002)]. Details on our RJMCMC and MC 3 implementations are given
in Fouskakis, Ntzoutras and Draper (2009a).
The MC 3 approach relies on posterior model odds POγ,γ′ , which are
not analytically available in this setting; because of this we also explored
two methods for calculating them—approximating the acceptance proba-
bilities with cost-adjusted Laplace [equation (18)] and cost-adjusted BIC
[equation (20)]—and, in addition, we further explored one additional form
of sensitivity analysis: initializing the MCMC runs at the null model (with
no predictors) and the full model (with all predictors). All of this was done
both for the benefit-only analysis using our method (setting all costs equal)
and the cost-benefit approach.
In moving from the full to the reduced model space to implement step (1)
of our two-step method, for both the benefit-only and cost-benefit analyses
we found a striking level of agreement, in the subset of variables defining the
reduced model space, as we varied (a) the two model search tools, (b) the
two methods to approximate the acceptance probabilities in MC 3, and (c)
the two choices for initializing the MCMC runs; this made it unnecessary to
perform similar sensitivity analyses in step (2). Results in the next section
are therefore presented only for RJMCMC (starting from the full model).
Convergence of the RJMCMC algorithm was checked using ergodic mean
plots of the marginal inclusion probabilities for the full model space and the
posterior model probabilities for the reduced space. Additional computing
details are available in Appendix A.
In what follows we refer to the cost-benefit results as “RJMCMC cost-
benefit,” but we could equally well have used the term “MC 3 with cost-
adjusted BIC” (or just “cost-adjusted BIC” for short), because the results
from the two MCMC methods were in such close agreement.
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Table 2
Preliminary RJMCMC results: variables with marginal posterior probabilities f(γj = 1|y)
above 0.30; costs are expressed in minutes of abstraction time
Marginal posterior probabilities
Variable RJMCMC analysis
Index Name Cost Benefit-only Cost-benefit
1 SBP score 0.50 0.99 0.99
2 Age 0.50 0.99 0.99
3 Blood urea nitrogen 1.50 1.00 0.99
4 APACHE II coma score 2.50 1.00
5 Shortness of breath day 1? 1.00 0.97 0.79
8 Septic complications? 3.00 0.88
12 Initial temperature 0.50 0.98 0.96
13 Heart rate day 1 0.50 0.34
14 Chest pain day 1? 0.50 0.39
15 Cardiomegaly score 1.50 0.71
27 Hematologic history score 1.50 0.45
37 APACHE respiratory rate score 1.00 0.95 0.32
46 Admission SBP 0.50 0.68 0.90
49 Respiratory rate day 1 0.50 0.81
51 Confusion day 1? 0.50 0.95
70 APACHE pH score 1.00 0.98 0.98
73 Morbid + comorbid score 7.50 0.96
78 Musculoskeletal score 1.00 0.54
Notes: (1) Abbreviation used in this table: SBP = systolic blood pressure. (2) Variables
with a question mark in their names were dichotomous answers to yes/no questions, scored
1 = yes and 0 = no; all other variables (except variable 1, which was also dichotomous)
were measured on quantitative scales with three or more possible values.
4. Experimental results.
4.1. Cost-benefit analysis with cost-adjusted BIC. Table 2 presents the
marginal posterior probabilities of the variables that exceeded the threshold
value of 0.30, in each of the RJMCMC benefit-only and cost-benefit analyses
in the reduced model space, together with their data collection costs. In both
the benefit-only and cost-benefit settings our methods reduced the initial list
of p= 83 available candidates down to 13 predictors. Note from Table 2 that
the most expensive variables with high marginal posterior probabilities in
the benefit-only analysis were absent from the set of promising variables in
the cost-benefit analysis (e.g., the Morbid + comorbid score, variable 73).
Similarly, some inexpensive variables with low marginal posterior probabili-
ties in the benefit-only analysis were included in most of the models visited
in the cost-benefit analysis (e.g., Confusion day 1?, variable 51). Note also
that there is not a strong degree of overlap between the 14 variables cho-
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Table 3
Reduced model space: posterior model probabilities above 0.03, posterior odds (PO1k) of
the best model within each analysis versus the current model k, and model costs
Common variables Additional Model Posterior
k within each analysis variables cost probabilities PO1k
Benefit-only analysis
1 X4 +X15 +X37 +X73 +X8 +X27 +X46 22.5 0.3066 1.00
2 +X8 +X27 22.0 0.1969 1.56
3 +X8 20.5 0.1833 1.67
4 +X27 +X46 19.5 0.0763 4.02
5 17.5 0.0383 8.00
Cost-benefit analysis
1 X46 +X51 +X49 +X78 7.5 0.1460 1.00
2 +X14 +X49 +X78 7.5 0.1168 1.27
3 +X13 +X49 +X78 7.5 0.0866 1.69
4 +X13 +X14 +X49 +X78 8.0 0.0665 2.20
5 +X14 +X49 7.0 0.0461 3.17
6 +X49 6.5 0.0409 3.57
7 +X37 +X78 7.5 0.0382 3.82
8 +X13 +X14 +X49 7.5 0.0369 3.96
9 +X13 6.5 0.0344 4.25
Common variables in both analyses: X1 +X2 +X3 +X5 +X12 +X70.
sen in the original RAND benefit-only analysis summarized in Table 1 and
the 13 variables with high marginal posterior probabilities in the RJMCMC
benefit-only part of Table 2; we return to this point below.
Table 3 presents models with posterior model probabilities above 0.03 (in
descending order), as well as posterior odds of the model with the highest
posterior probability compared to the remaining ones. In both types of anal-
ysis, the variables Systolic blood pressure score (X1), Age (X2), Blood urea
nitrogen (X3), Shortness of breath (X5), Temperature (X12) and APACHE pH
score (X70) were included in all the highest probability models, with costs
(in minutes) 0.5, 0.5, 1.5, 1.0, 0.5 and 1.0 respectively.
For the cost-benefit analysis, 9 models had posterior probabilities above
0.03. In all of these models Admission systolic blood pressure (SBP; X46)
and Confusion day 1 (X51) were present (both having the lowest cost of
0.5 minutes). Predictors Respiratory rate day 1 (X49) and Musculoskeletal
score (X78) were also frequently included in the top nine models (in 7 and
5 of the 9 cases, respectively). Both of these variables were present in the
four highest probability models, with similar posterior probabilities; in fact,
there were no substantial differences between those models (note that the
posterior odds of models 2–4 in the cost-benefit part of Table 3 differed from
those of model 1 by factors of no more than three, indicating evidence “not
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worth more than a bare mention” [cf. Raftery (1996)] in favor of model 1).
All variables included in the highest probability models had costs of at most
one minute with the exception of Blood urea nitrogen (X3), which had a cost
of 1.5.
In the RJMCMC benefit-only analysis, 5 models had posterior probabil-
ities above 0.03. In all of these models APACHE II coma score (X4), Car-
diomegaly score (X15), APACHE respiratory rate score (X37) and Morbid +
comorbid score (X73) were present, having costs of 2.5, 1.5, 1.0 and 7.5 min-
utes (respectively). Note that the costs of the best models in the benefit-only
analysis are 2.2 to 3.5 times higher than the costs of the best models from
the cost-benefit analysis.
Since in the RJMCMC cost-benefit analysis we increase the penalty of
relatively expensive variables in the prior, we end up selecting more par-
simonious models in terms of both dimensionality and cost. It is therefore
interesting to examine the loss in terms of prediction and goodness of fit.
We use the posterior distribution of the deviance statistic
D(βγ,γ) =−2
n∑
i=1
log f(yi|βγ,γ)(22)
[Dempster (1974); Spiegelhalter et al. (2002)] as a measure of model fit.
Usually attention focuses on the minimum value of this posterior distribution
(which sometimes is poorly estimated by MCMC runs), but other posterior
descriptive measures such as the median or mean provide adequate measures
of fit [Spiegelhalter et al. (1996)].
In Table 4 we present the minimum and median values of the posterior
distribution of the deviance statistic, together with the cost and dimension
of the best models found with both types of analysis. Two main points are
worth noting:
• Two approaches to the creation of a benefit-only analysis may now be
compared: the frequentist approach employed in the original RAND study
and our RJMCMC benefit-only analysis obtained by setting all the costs
equal. The deviance statistic for the benefit-only RAND model summa-
rized in Table 1 turned out to be 1587.3 (achieved with 14 predictors),
substantially worse than the median deviance (1564.5, achieved with 13
predictors) of the best model visited by the benefit-only approach exam-
ined in this paper; in other words, in this case study, frequentist backward
selection from the model with all predictors (the RAND approach) was
substantially out-performed by Bayesian RJMCMC.
• The minimum and median values of the posterior distribution of the de-
viance statistic for the RJMCMC benefit-only analysis were lower by a
relatively modest 5.3% and 5.1% compared to the corresponding values of
the cost-benefit analysis, but the cost of the best model in the cost-benefit
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Table 4
Comparison of measures of fit, cost and dimensionality between the best models in the
reduced model space of the RJMCMC benefit-only and cost-benefit analyses; percentage
difference is in relation to benefit-only
RJMCMC analysis
Percentage
differenceBenefit-only Cost-benefit
Minimum deviance 1553.2 1635.8 +5.3
Median deviance 1564.5 1644.8 +5.1
Cost 22.5 7.5 −66.7
Dimension 13 10 −23.1
analysis was almost 67% lower than that for the benefit-only analysis; sim-
ilarly, the dimensionality of the best model in the cost-benefit analysis was
about 23% lower than that for the benefit-only analysis. These values in-
dicate that the loss of predictive accuracy with the cost-benefit analysis
is small compared to the substantial gains achieved in cost and reduced
model complexity.
An alternative predictive measure of fit is the cross-validation log score
LSCV , following ideas of Geisser and Eddy (1979) and Gelfand et al. (1992)
[also see, e.g., Draper and Krnjajic´ (2009)]. It is based on leave-one-out
predictive distributions f(yi|y\i) and is given by
LSCV (γ|y) =
1
n
n∑
i=1
log f(yi|y\i,γ),(23)
where y\i is the vector of data y without observation i (larger values of
LSCV indicate greater predictive accuracy). This measure can be estimated
directly from a single MCMC run using the formula
L̂SCV (γ|y) =−
1
n
n∑
i=1
log f−1(yi|βγ,γ),(24)
where f−1(yi|βγ,γ) is the posterior mean of the inverse of the predictive
density for observation i [for details see, e.g., Gelfand (1996), pages 154–155].
We calculated L̂SCV for the models with the highest posterior probability
for each RJMCMC analysis and obtained a value of −0.312 for the best
model of the benefit-only analysis and −0.327 for that of the cost-benefit
analysis; the latter is 4.8% smaller than the former, in line with the last
column of Table 4, and, as before, this small loss in predictive accuracy is
accompanied by the 66% drop in cost and 15% decrease in model complexity
achieved by the cost-benefit approach.
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Table 5
The full set of 83 variables, together with their data collection costs per patient and their
status according to the utility and RJMCMC methods; columns 4 and 5 are explained in
the text
Variable Method
Index Name Cost cj (minutes) Utility RJMCMC
1 Systolic BP score 0.5 ∗∗ ∗∗
2 Age 0.5 ∗∗
3 Blood urea nitrogen 1.5 ∗∗ ∗∗
4 APACHE II coma score 2.5 ∗∗
5 Shortness of breath day 1? 1.0 ∗ ∗∗
6 Serum albumin score 1.5
7 Respiratory distress? 1.0
8 Septic complications? 3.0
9 Prior respiratory failure? 2.0
10 Recently hospitalized? 2.0
11 Racbilateral process score 1.5
12 Initial temperature 0.5 ∗∗ ∗∗
13 Heart rate day 1 0.5 ∗ ∗
14 Chest pain day 1? 0.5 ∗ ∗
15 Cardiomegaly score 1.5
16 Plural effusion score 1.5
17 CXR CHF score 2.5
18 Ambulatory score 2.5
19 Endocarditis at admission? 1.5
20 CPK score 2.0
21 Prior antibiotics? 0.5
22 Prior interstitial lung disease? 0.5
23 Home oxygen use? 1.0
24 Prior pneumonectomy? 0.5
25 Prior tracheostomy? 0.5
26 Prior aminophylline score 0.5
27 Hematologic history score 1.5
28 Cancer score 1.5
29 APACHE heart rate score 1.5
30 Corodaker score 1.0
31 Disease of thorax? 1.0
32 Multiple myeloma? 0.5 ∗
33 Immunocompromised? 0.5
34 Residence score 1.0
35 Hepatobiliary history? 0.5
36 Renal history score 1.0
37 APACHE respiratory rate score 1.0 ∗ ∗
38 New lung score 1.0
39 Co-morbid aspiration score 0.5 ∗
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Table 5
(Continued.)
Variable Method
Index Name Cost cj (minutes) Utility RJMCMC
40 APACHE sodium score 2.0
41 APACHE hematocrit score 1.5
42 APACHE WBC score 1.5
43 APACHE oxygenation score 1.5
44 CVA score 1.0
45 APACHE potassium score 1.0
46 Admission SBP 0.5 ∗∗ ∗∗
47 CHF Chest X-ray score 2.5
48 Total APACHE II score 10.0
49 Respiratory rate day 1 0.5 ∗∗ ∗∗
50 DBP day 1 0.5
51 Confusion day 1? 0.5 ∗ ∗∗
52 PVC score 0.5
53 APACHE VB score 1.5
54 Pulmonary edema score 0.5
55 Sum of CHF components 5.5
56 Influenza score 0.5 ∗
57 Arrest in ER score 0.5 ∗
58 Biliribin score 1.5
59 Positive blood culture? 0.5
60 Positive urine culture? 0.5
61 Wheezing at admission? 0.5
62 Body system count 2.5
63 Morbid prior COPD score 0.5
64 Morbid PHS 0.5
65 Co-morbid cirrhosis score 0.5 ∗
66 Co-morbid CHF score 0.5 ∗
67 Co-morbid arrhythmias score 0.5
68 Co-morbid smoking score 0.5
69 Co-morbid alcoholism score 0.5 ∗
70 APACHE pH score 1.0 ∗∗
71 Co-morbid NGTs score 0.5
72 Co-morbid steroids score 0.5 ∗
73 Morbid + comorbid score 7.5
74 Cardiac history score 0.5
75 Neurologic history score 0.5 ∗
76 Oncologic history score 0.5
77 Immunologic history score 0.5
78 Musculoskeletal score 0.5 ∗ ∗∗
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Table 5
(Continued.)
Variable Method
Index Name Cost cj (minutes) Utility RJMCMC
79 APACHE temperature score 1.0
80 APACHE mean BP score 1.0
81 APACHE creatinine score 1.0
82 DX score 1.0
83 Sex of patient 0.5
Notes: (1) Abbreviations used in this table: BP = blood pressure, CHF = congestive heart
failure, COPD = chronic obstructive pulmonary disease, CVA = cardiovascular accident,
CXR = chest X-ray, DBP = diastolic blood pressure, DX= diagnoses, NGT= naso-gastric
tube, PHS = pulmonary hospitalization score, PVC = pulmonary vascular congestion,
SBP = systolic blood pressure, VB = venous bicarbonate. (2) Variables with a question
mark in their names were dichotomous answers to yes/no questions, scored 1 = yes and
0 = no; all other variables (except variable 1, which was also dichotomous) were measured
on quantitative scales with three or more possible values.
4.2. Comparison of cost-benefit analyses: utility versus cost-adjusted BIC.
The RJMCMC cost-benefit results so far have been based on our cost-
adjusted BIC approach; other cost-benefit methods are possible, including a
decision-theoretic approach involving (a) explicit quantification of costs and
benefits via a utility function followed by (b) maximization of expected util-
ity. Columns 4–6 in Table 1 present a comparison of the maximum-expected-
utility method of Fouskakis and Draper (2008)3 and the RJMCMC method
of this paper—which (as noted above) is functionally equivalent to our cost-
adjusted BIC method—when the space of predictor variables is defined by
the p= 14 variables in the original RAND scale described in Section 1, and
Table 5 offers a comparison of the two methods when all p = 83 variables
collected in the RAND study served as the basis of the variable selection
search. In columns 4 and 5 of Table 1, two stars signify that a variable ap-
peared in the best model found by each method [for RJMCMC this model
is given in Table 6(B)], and one star in column 4 means that the variable
often appeared in the 20 best models identified by the utility approach.
It is evident that the two methods arrived at similar conclusions with
p = 14: six variables were chosen by neither method (note from column 6
3Fouskakis and Draper (2008) used stochastic optimization methods—including sim-
ulated annealing, genetic algorithms and tabu search [see Draper and Fouskakis (2000),
and Fouskakis and Draper (2002)]—to find (near-) optimal subsets of predictor variables
that maximize an expected utility function that trades off data collection cost against
predictive accuracy in a way that is sensitive to the policy implications of searching for
“good” and “bad” hospitals; utility elicitation details are available in Fouskakis, Ntzoufras
and Draper (2009a).
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Table 6
(A) Summary of the RJMCMC cost-benefit search results in the p= 14 case. (B)
Comparison of the utility and RJMCMC methods in how their best models trade off cost
and predictive accuracy
A
Model Cost Posterior probability PO1k
X1 +X2 +X3 +X4 +X5 +X6 +X7 +X12 9.0 0.453 1.00
X1 +X2 +X3 +X4 +X5 +X7 +X12 7.5 0.415 1.09
X1 +X2 +X3 +X4 +X5 +X6 +X12 8.0 0.054 8.40
X1 +X2 +X3 +X4 +X5 +X6 +X7 8.5 0.031 14.72
B
p Method Model Cost Median deviance LSCV
14
RJMCMC
X1 +X2 +X3 +X4 +X5 +X6 +X7 +X12 9.0 1654 −0.329
X1 +X2 +X3 +X4 +X5 +X7 +X12 7.5 1676 −0.333
Utility X1 +X3 +X4 +X5 5.5 1726 −0.342
83
RJMCMC
X1 +X2 +X3 +X5 +X12
+X46 +X49 +X51 +X70 +X78
7.5 1645 −0.327
Utility
X1 +X3 +X4 +X12
+X46 +X49 +X57
6.5∗ 1693 −0.336
∗This model had a higher cost than the best model with p= 14 because the utility approach
was not optimizing on cost but on a utility-based cost-benefit tradeoff.
in Table 1 that all of these variables had marginal posterior probability 0
in the RJMCMC method); four more variables had identical star patterns;
and the other four variables were chosen by both methods as important,
differing only in how many stars they received. Table 5 uses a similar star
system: two stars in columns 4 and 5 in this table signify membership in the
globally best model found by the utility and RJMCMC methods, respec-
tively; one star in column 4 means that the variable appeared frequently in
the 100 best utility models [see Fouskakis and Draper (2008) for details],
with one star in column 5 signifying that a variable often occurred in the
highest-posterior-probability RJMCMC models of Table 3. With p= 83, the
agreement between the two methods is also strong (although not as strong
as with p= 14): 60 variables were ignored by both methods, eight variables
had identical star patterns, three variables were chosen as important by
both methods but with different star patterns, 10 variables were marked as
important by the utility approach and not by RJMCMC, and two variables
were singled out by RJMCMC and not by utility (this represents substantial
agreement on the importance of 85% of the variables).
Table 6 gives a summary of the RJMCMC search results with p= 14 and
examines the cost-benefit tradeoffs of the utility and RJMCMC methods in
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more detail. It is clear that, to the extent that the two approaches differ,
the utility method favors models that cost somewhat less but also predict
somewhat less well. The fact that the two methods yield somewhat different
results does not mean that either is wrong; they are both valid solutions to
similar but not identical problems. Both methods lead to noticeably better
models (in a cost-benefit sense) than frequentist or Bayesian benefit-only ap-
proaches, when—as is often the case—cost is an issue that must be included
in the problem formulation to arrive at a policy-relevant solution.
5. Discussion. In this paper we have examined a relatively new per-
spective on Bayesian variable selection, when data collection costs need to
be traded off against predictive accuracy in choosing an optimal subset of
predictors. We propose a prior setup that accounts for the cost of each vari-
able and we utilize traditional posterior model odds for the evaluation of
models. This leads to a set of posterior model probabilities that correspond
approximately to a generalized cost-adjusted version of BIC. Computation
is performed using reversible-jump MCMC in two stages: first, to reduce
the model space by dropping variables with low marginal posterior proba-
bilities, and then to estimate posterior model probabilities in the reduced
space. We have applied our methodology to the problem of cost-effective
input-output quality measurement in a health policy setting, with a binary
outcome and a large number (p= 83) of predictors that differ substantially
in data-collection costs. The resulting models achieve dramatic gains in cost
and noticeable improvement in model simplicity at the price of a small loss
in predictive accuracy, when compared to the results of a more traditional
benefit-only analysis.
As noted in Section 1.3, the problem we address here can also be ap-
proached via an alternative version of cost-benefit analysis (based on max-
imizing expected utility) and/or a cost-restriction-benefit analysis (maxi-
mizing predictive accuracy subject to a bound on cost); the latter approach
[Fouskakis, Ntzoufras and Draper (2009b)] is not directly comparable to the
other two methods. We have compared our cost-adjusted BIC approach with
the utility-based method developed by Fouskakis and Draper (FD) (2008),
finding that the two approaches lead to similar cost-benefit variable sub-
sets. The decision-theoretic approach has the drawback that it may not be
possible to find a single utility structure capturing the preferences of all rel-
evant stakeholders (including patients, doctors, hospitals, citizen watchdog
groups, and state and federal regulatory agencies) in the quality-of-care-
assessment process (utility was assessed from only a single viewpoint in
FD). The cost-adjusted BIC approach developed here offers an alternative
that avoids ambiguity in utility specification.
The method we have described in this paper appears to hold significant
promise for cost-effective input-output quality and performance assessment.
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It can be applied in any setting where the outcome is binary, such as in edu-
cation (with outcomes such as drop-out during university study and employ-
ment following graduation) and business (with outcomes such as retention
in the workplace and the default status of a loan), and can be implemented
with minor modifications for any other generalized linear model. We believe
that the scope of applications of regression methodology in which
(a) the purpose of the model-building is to create a predictive scale and
(b) future use of the scale created in (a) will take place in a cost-constrained
environment with nonzero data collection costs
is sufficiently broad that methods like those examined here are worthy, both
of consideration now, for practical adoption, and of further study to promote,
for example, additional computational efficiency gains.
APPENDIX A
Here we give a proof of Theorem 1 and the statement and proof of Corol-
lary 1.
Proof of Theorem 1. To begin with condition (a) in Section 2.2.2, it
is straightforward to show that this is satisfied if and only if the costs enter
into the prior through functions of the ratios
cj
cj′
, or equivalently, through
functions of ratios
cj
c0
for some c0 > 0.
From condition (b), the extra penalty ξ1 when comparing two models
(γj = 1,γ\j) and (γj = 0,γ\j) that differ only by variable Xj with cost c0 is
given by
ξ1[(γj = 1,γ\j), (γj = 0,γ\j)] =−2 log
f(γj = 1,γ\j)
f(γj = 0,γ\j)
= 0
(25)
⇔
f(γj = 1|γ\j)
1− f(γj = 1|γ\j)
= 1 ⇔ f(γj = 1|γ\j) =
1
2
.
Since the above must be true for all γj and γ\j , the result is f(γj = 1) =
1
2
when the cost of a variable Xj equals the baseline cost c0.
Similarly, for two models (γj = 1,γ\j) and (γj = 0,γ\j) that differ only
by variable Xj with cost cj = κc0, from condition (c) we have
ξ2[(γj = 1,γ\j), (γj = 0,γ\j)] =−2 log
f(γj = 1|γ\j)
f(γj = 0|γ\j)
= (κ− 1) logn
⇔ f(γj = 1|γ\j) =
exp[−(1/2)(κ− 1) logn]
1 + exp[−(1/2)(κ− 1) logn]
.
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Since the above equation must hold for any γj ,γ\j and κ=
cj
c0
, we end up
with a prior of the form (15).
From condition (d) we have to set c0 ≤ min{cj , j = 1, . . . , p}, since any
other choice will result in negative prior penalties for variables with cost
less than c0. Furthermore, if cj = c
′ ≥ c0 for all j, then from (c),
f(γj = 1) =
exp[−(1/2)(c′/c0 − 1) logn]
1 + exp[−(1/2)(c′/c0 − 1) logn]
,(26)
resulting in
f(γ)∝
{exp[−(1/2)(c′/c0 − 1) logn]}
∑p
j=1
γj
{1 + exp[−(1/2)(c′/c0 − 1) logn]}p
.(27)
Under condition (e), for any two models γ(k) and γ(ℓ) the prior model odds
must equal to one. Hence,
f(γ(k))
f(γ(ℓ))
= 1,(28)
resulting in
p∑
j=1
(γ
(k)
j − γ
(ℓ)
j )
[
−
1
2
(
c′
c0
− 1
)
logn
]
= 0 for any γ(k),γ(ℓ).(29)
The above is satisfied for any pair of models if and only if c′ = c0. Hence,
c0 =min{cj , j = 1, . . . , p} is the only choice under which (e) is satisfied when
(b), (c) and (d) also hold. 
Corollary 1. If a prior distribution f(γ) is such that:
(a′) the imposed penalty ω on the log-likelihood ratio for adding a variable
Xj with cost κ times the baseline cost c0 (for positive integer κ) equals
the imposed penalty for adding κ variables with the baseline cost c0,
(b′) the imposed penalty ω for each additional variable is at least equal to
logn (the BIC penalty for the benefit-only analysis), and
(c′) if all costs are equal, the imposed penalty ω when comparing any two
models γ(k) and γ(ℓ) is (dγ(k) − dγ(ℓ)) logn (the BIC penalty),
then it must be of the form (15).
Proof. If we compare two models that differ only by a variable Xj with
cost cj = κc0, then from (a
′),
ω[(γj = 1,γ\j), (γj = 0,γ\j)] = κ logn for all j = 1, . . . , p,(30)
which results in
ξ[(γj = 1,γ\j), (γj = 0,γ\j)] = (κ− 1) logn for all j = 1, . . . , p,(31)
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from (21). The above expression corresponds to the third requirement of
Theorem 1 used to construct our proposed prior distribution. Moreover, the
second requirement of the same theorem arises as a special case for κ= 1.
From (b′) we have that
ω[(γj = 1,γ\j), (γj = 0,γ\j)]≥ logn for all j = 1, . . . , p,(32)
resulting in
ξ[(γj = 1,γ\j), (γj = 0,γ\j)]≥ 0 for all j = 1, . . . , p,(33)
which corresponds to the fourth requirement of Theorem 1.
Finally, from (c′), if all costs are equal, then
ω(γ(k),γ(ℓ)) = (dγ(k) − dγ(ℓ)) logn,(34)
resulting in
ξ(γ(k),γ(ℓ)) = 0 for all γ(k) and γ(ℓ),(35)
and thus,
f(γ(k))
f(γ(ℓ))
= 1(36)
for any pair of compared models. Hence, the induced prior when all costs
are equal must be uniform on γ, that is, f(γ)∝ 1 for all γ. This corresponds
to the fifth requirement used to construct our prior in Theorem 1.
Since each of the above statements is equivalent to the requirements used
to build our prior in Theorem 1, the only prior with the above three prop-
erties is (15). 
APPENDIX B: COMPUTING DETAILS FOR THE MCMC-BASED
COST-BENEFIT ANALYSIS
With reference to the MCMC methods described in Section 3, both the
coding time and the running time of RJMCMC were higher than with either
variant of MC 3 to achieve comparable MCMC accuracy. All MC 3 runs in
the full model space were based on 10,000 monitoring iterations after a burn-
in (from either the null model or the full model) of 1,000 iterations; each
of these runs took 2–3 days (on a Pentium 4 machine at 2.8 GHz with 512
MB RAM) for the cost-adjusted Laplace variant of MC 3 and 1–2 days for
the cost-adjusted BIC variant (these are run times for an implementation in
R; coding the same algorithms in C would have yielded substantially faster
run times, on the order of 6–8 hours for Laplace and 2–5 hours for BIC). To
achieve reasonable run times for RJMCMC, it was necessary to implement
the algorithm in C. RJMCMC runs were based on 100,000 iterations, after
discarding an initial 10,000 iterations as a burn-in; each of these runs took 2–
3 days in the full model space and 9 hours in the reduced space. The resulting
R and C programs are available upon request from the first or second authors
of this paper.
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SUPPLEMENTARY MATERIAL
Cost-based prior distributions for variable selection in generalized lin-
ear models (DOI: 10.1214/08-AOAS207SUPP; .pdf). Imaginary data and
power-prior motivation for the prior distribution in the main paper’s equa-
tion (6) and details on RJMCMC and MC 3 implementation and utility
elicitation.
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